Skip to Content

221 (Januvia 25 mg)

Generic Name: sitagliptin

Pill with imprint 221 is Pink, Round and has been identified as Januvia 25 mg. It is supplied by Merck & Company Inc..

Januvia is used in the treatment of diabetes, type 2 and belongs to the drug class dipeptidyl peptidase 4 inhibitors. There is no proven risk in humans during pregnancy. Januvia 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 221

Januvia

Generic Name
sitagliptin
Imprint
221
Strength
25 mg
Color
Pink
Size
6.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Dipeptidyl peptidase 4 inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Merck & Company Inc.
National Drug Code (NDC)
00006-0221
Inactive Ingredients
calcium phosphate dibasic anhydrous, croscarmellose sodium, magnesium stearate, microcrystalline cellulose, ferric oxide red, sodium stearyl fumarate, magnesium silicate, titanium dioxide, ferric oxide yellow

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "221"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.